Mar 15, 2022 / 12:30PM GMT
Luke England Sergott - Barclays Bank PLC, Research Division - Research Analyst
Morning, everybody. My name is Luke Sergott, I cover life science tools here at Barclays. It's my pleasure to have Mary Anne Heino from Lantheus Holdings, which she's going to give us an update in our presentation today.
Mary Anne Heino - Lantheus Holdings, Inc. - CEO, President & Director
Thank you, Luke, and good morning, everyone. As Luke said, I'm Mary Anne Heino, I am President and Chief Executive Officer of Lantheus. I will warn you, I have a lot of material here today, so I'll move through some of it quickly, so we can get some questions if we have them.
The first thing I have to show is the safe harbor statement. So please, this is also available on our website. Please take a moment to read it there, but this says you should very much interpret what I say as my opinion and the opinion of the company and not necessarily a reason to invest, although I do think it's a great idea. So why don't we get into the presentation.
For those of you who are not aware,
Lantheus Holdings Inc at Barclays Global Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers